Diffuse coronary artery disease is a subtype of coronary artery disease (CAD) in which larger sections of coronary arteries have a high plaque buildup. It is less common than focal CAD and can be more ...
Modeyso is the first FDA-approved systemic therapy for H3 K27M-mutant diffuse midline glioma, targeting both adult and pediatric patients. Clinical trials demonstrated a 22% overall response rate with ...
Hypofractionated radiation therapy with concurrent and adjuvant temozolomide is conditionally recommended for elderly patients. HealthDay News — In a clinical practice guideline issued by the American ...
Efficacy and safety of the use of dinutuximab in newly diagnosed or relapse high risk neuroblastoma: Single arm systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials Histone 3 (H3) K27M–mutant diffuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results